Rodents Versus Pig Model for Assessing the Performance of Serotype Chimeric Ad5/3 Oncolytic Adenoviruses
Oncolytic adenoviruses (Ad) are promising tools for cancer therapeutics. Most Ad-based therapies utilize species C serotypes, with Adenovirus type 5 (Ad5) most commonly employed. Prior clinical trials demonstrated low efficiency of oncolytic Ad5 vectors, mainly due to the absence of Ad5 primary rece...
Main Authors: | Lisa Koodie, Matthew G. Robertson, Malavika Chandrashekar, George Ruth, Michele Dunning, Richard W. Bianco, Julia Davydova |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/2/198 |
Similar Items
-
Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus
by: Sam Illingworth, et al.
Published: (2017-06-01) -
A Tumor-Targeted Replicating Oncolytic Adenovirus Ad-TD-nsIL12 as a Promising Therapeutic Agent for Human Esophageal Squamous Cell Carcinoma
by: Zifang Zhang, et al.
Published: (2020-11-01) -
Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35
by: Ryosuke Ono, et al.
Published: (2021-03-01) -
Modeling the Efficacy of Oncolytic Adenoviruses In Vitro and In Vivo: Current and Future Perspectives
by: Mary K. McKenna, et al.
Published: (2020-03-01) -
Oncolytic Adenoviruses in Cancer Treatment
by: Ramon Alemany
Published: (2014-02-01)